Trials / Withdrawn
WithdrawnNCT02159794
HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- HLT Inc. · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at High Risk for aortic valve replacement surgery.
Detailed description
Prospective, non-randomized, single arm, single-center first-in-man feasibility trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HLT Transcatheter Aortic Valve System | Transcatheter aortic valve replacement with an HLT Transcatheter Aortic Valve System |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-12-01
- Completion
- 2020-03-01
- First posted
- 2014-06-10
- Last updated
- 2015-03-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02159794. Inclusion in this directory is not an endorsement.